Martha Connolly Inducted into American Institute for Medical and Biological Engineering College of Fellows

 Martha Connolly Inducted into American Institute for Medical and Biological
                        Engineering College of Fellows

PR Newswire

COLLEGE PARK, Md., March 7, 2013

Joins top two percent in medical and biological engineering

COLLEGE PARK, Md., March 7, 2013 /PRNewswire-USNewswire/ --Martha Connolly,
director of the Maryland Industrial Partnerships (MIPS) program in the
Maryland Technology Enterprise Institute at the University of Maryland, has
been inducted into the College of Fellows by the American Institute for
Medical and Biological Engineering (AIMBE), institute officials announce


AIMBE is the leading advocacy group for medical and biological engineering,
with practitioners in academia, industry and government. The College of
Fellows is comprised of the top two percent of medical and biological
engineers in the country, including school chairs, research directors,
innovators, and successful entrepreneurs.

Connolly was named fellow for "outstanding contributions to the field of
technology commercialization of biomedical technologies that resulted in
demonstrated economic benefits."

"Martha Connolly is one of the most respected and admired experts in the area
of technology development," said Lisbeth Pettengill, vice president of the
Greater Baltimore Committee. "Her leadership has made MIPS one of the most
successful programs in the United States, with measurable outcomes that have
resulted in the formation of some of Maryland's most outstanding companies.
She gives tirelessly of her expertise and her energy, not only to the
professional communities with which she interacts, but also to her countless
friends and admirers."

As head of the MIPS program for nearly a decade, where nearly 40 percent of
the funding for technology product research is awarded to projects led by
bioscience companies, Connolly has supported the development of products for
companies such as MedImmune, CSA Medical, WellDoc, PharmAthene, GenVec,
Innovative Biosensors, 20/20 Gene Systems, Alba Therapeutics, A&G
Pharmaceuticals and Gliknik.

"Dr. Connolly has been a tireless advocate for CSA Medical and the life
science and technology industries in Maryland," said CSA Medical Inc.'s Chief
Financial Officer Steven Schaefer."The combination of her keen insights into
business, her knowledge of the political arena and her academic connections
make for a powerful combination that helped us find targeted programs to move
our Company forward. We are very grateful for her support."

Blockbuster and emerging products developed by Maryland companies have
benefited from MIPS, including Martek Biosciences' nutritional oils, Hughes
Communications' HughesNet™, MedImmune's Synagis®, Black & Decker's Bullet®
Speed Tip Masonry Drill Bit, WellDoc's mobile diabetes management platform,
and CSA Medical's diseased-tissue ablation device. Products with MIPS projects
have generated more than $25.2 billion in revenue and added thousands of jobs
to the region.

"Martha has inspired students, faculty, and entrepreneurs to push technologies
into the marketplace," said William Bentley, professor and chair of the
Fischell Department of Bioengineering in the Clark School of Engineering. "She
has developed innovative programs that stimulate entrepreneurship and economic
development broadly, and her fellowship in AIMBE recognizes just one aspect of
her work in the translation of technological advances towards the medical and
biotechnology industries."

Connolly has connected and mentored many bioscience companies and faculty in
the University System of Maryland. Among those is Charlene Quinn, associate
professor in the University of Maryland School of Medicine, who worked with
Baltimore-based WellDoc through MIPS to evaluate the company's flagship
product, DiabetesManager, which helps doctors and patients with type 2
diabetes work together by providing for the capture, storage and real-time
transmission of blood glucose data and other diabetes self-management
information in a highly secure environment. Quinn's MIPS study showed that
adults with type 2 diabetes using WellDoc's software achieved a 2.03-point
reduction in A1c, an indicator used to identify the average blood glucose
level of a diabetic over a 12-week time period.

"Dr. Martha Connolly has been a valuable mentor and colleague assisting me in
establishinga strong research career with partnerships in the private sector
and national research communities," said Quinn. "Her work has made a
significant contribution to scientific communities, private enterprise and
economic development. Her enthusiasm for building collaborations between
science and the private sector is worthy of the distinction bestowed by the

Overall, Connolly has served as a leader in the Maryland bioscience industry
for more than 25 years. She was the first biotechnology advocate hired at the
state level when she joined the Maryland Department of Business and Economic
Development (DBED) in 1997 to foster the state's fledgling bioscience
industry. In that capacity, she helped plant the seeds for what is now a
significant industry in the state.

During her time at DBED, Connolly helped grow the Maryland bioscience
community from 300 to 450 businesses. She also put Maryland on the map in the
international bio community as the place where the human genome was sequenced.

"Martha combines vast experience and academic know how with pragmatism and an
understanding of the real world, enabling her to connect with individuals of
all backgrounds and perspectives," said David Ianucci, assistant deputy CAO
for economic development and public infrastructure at Prince George's
County."She is widely respected, but most importantly, people like Martha."

Connolly also directed business development activities at EntreMed Inc., a
publicly traded biopharmaceutical company, and co-founded the startup
technology development/commercialization firm Clairus Technologies Inc.

Connolly was the first woman to graduate from The Johns Hopkins University's
biomedical engineering doctoral program. She was also among the first class of
co-eds at the Stevens Institute of Technology.

As a former faculty member and director of an independent research laboratory
at the University of Maryland, Baltimore, Connolly worked on funded research
from both the National Institutes of Health and the American Lung Association
in the area of cardiovascular systems physiology and bioengineering. She also
authored 37 full-length, peer-reviewed publications in those areas.

Connolly is a member of the GBC Bioscience Committee, where she donates her
time and expertise toward advocacy efforts for the bioscience community.

The long process for new AIMBE Fellows began with nominations by their peers
early last year. Each nominee was also screened by committees of Fellows
within their bioengineering specialty. Finally, a final election by the entire
College of Fellows was completed in late 2012.

Since 1991, the College of Fellows has led the way for technological growth
and advancement in medical and biological engineering. Fellows have helped
revolutionize medicine and related fields in order to enhance and extend the
lives of people all over the world. They have also successfully advocated for
public policies that have enabled researchers and business-makers to further
the interests of engineers, scientists, and patients.

For a photo of Connolly being inducted in the College of Fellows, visit:

SOURCE Maryland Technology Enterprise Institute

Contact: Eric Schurr, +1-301-405-3889,
Press spacebar to pause and continue. Press esc to stop.